NHS: Drugs
Commons · Question 9677 · Tabled 15 Jun 2026 · Department of Health and Social Care · Official record
Answered 29 Jun 2026
Question
Asked by Lee Anderson
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure Integrated Care Boards evaluate medicines for clinical effectiveness in a timely manner.
Answer
Answered by Preet Kaur Gill, 29 Jun 2026
Fezolinetant is a non-hormonal medicine used to treat moderate to severe hot flushes and night sweats linked to menopause. It may be used where hormone replacement therapy is not suitable.The National Institute for Health and Care Excellence (NICE) publis...